nach oben

European Archives of Psychiatry and Clinical Neuroscience

Erschienen in:

01.10.2007 | ORIGINAL PAPER

Psychiatric comorbidity and functional impairment in a clinically referred sample of adults with attention-deficit/hyperactivity disorder (ADHD)

verfasst von: Esther Sobanski, Daniel Brüggemann, Barbara Alm, Sebastian Kern, Monika Deschner, Thomas Schubert, Alexandra Philipsen, Marcella Rietschel

Erschienen in: European Archives of Psychiatry and Clinical Neuroscience | Ausgabe 7/2007

Einloggen, um Zugang zu erhalten

Abstract

Objective

This exploratory study aims to compare lifetime psychiatric axis-I-comorbidity and psychosocial functioning in a clinically referred sample of adult patients with attention-deficit/hyperactivity disorder (ADHD) with a population-based healthy control group and to examine whether patients with ADHD and lifetime comorbid diagnoses differ from patients with pure ADHD in their functional impairment.

Method

Seventy adult patients with ADHD according to DSM-IV criteria and a gender- as well as age-matched population based control group underwent diagnostic evaluations with clinical interviews for ADHD, DSM-IV disorders and demographic information.

Results

The prevalence of psychiatric lifetime comorbidity was 77.1% in patients with ADHD and thus exceeded the rate in the control group, which was 45.7%. Significantly more patients suffered from depressive episodes, substance related disorders and eating disorders. Compared to the control group adults with ADHD were significantly impaired in a variety of psychosocial functions (education, occupational training). Patients with ADHD and lifetime diagnosis of comorbid psychiatric disorders differed from patients with pure ADHD in their psychosocial functioning only in the percentage of unemployed individuals, which was higher in patients with psychiatric comorbidity.

Conclusion

Adults with ADHD suffer significantly more often from other psychiatric disorders than individuals of the population-based control group and are impaired in several areas of psychosocial functioning. Poor psychosocial outcome is primarily related to ADHD and not to additional psychiatric disorders. Due to the limited number of assessed patients these results need to be confirmed by studies with larger sample size.

Akiskal HS, Burgeois ML, Angst J, Post R, Möller H, Hirschfeld R (2000) Re-evaluating the prevalence of and diagnostic composition within the broad sprectrum of bipolar disorders. J Affect Disorders 59:S5–S30CrossRefPubMed

American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Press, Washington, DC

Barkley RA (2002) Major life activity and health outcomes associated with attention-deficit/hyperactivity disorder. J Clin Psychiatry 63(12):10–15PubMed

Berger M (1999) Affective disorders. In: Berger M (ed) Psychiatry and psychotherapy. Urban & Schwarzenberg, München, Wien, Baltimore

Biederman J, Faraone SV, Spencer T, Wilens T, Norman D, Lapey KA, et al. (1993) Patterns of comorbidity, cognition and psychosocial functioning in adults with attention-deficit hyperactivity disorder. Am J Psychiatry 150(12):1792–1797PubMed

Biederman J, Wilens T, Mick E, et al. (1995) Psychoactive substance use disorders in adults with attention deficit hyperactivity disorder (ADHD): effects of ADHD and psychiatric comorbidity. Am J Psychiatry 152:1652–1658PubMed

Brown TE (1996) Brown attention-deficit disorder scales manual. The Psychological Corporation, San Antonia

Curran S, Newman S, Taylor E, Asherson P (2000) Hypescheme: an operational criteria checklist for molecular genetic studies of attention deficit and hyperactivity disorders. Am J Med Genet 96(3):244–250CrossRefPubMed

Dukarm CP (2005) Bulimia nervosa and ADHD: a possible role for stimulant medication. J Womens Health Gend Based Med 14(4):345–50

10.

Dwivedi KN, Banhatti RG (2005) Attention deficit/hyperactivity disorder and ethnicity. Arch Dis Child 90(1):10–12CrossRef

11.

Fangerau H, Ohlraun S, Granath RO, Nöthen MM, Rietschel M, Schulze TG (2004) Computer-assisted phenotype characterization for genetic research in psychiatry. Hum Hered 58:122–130CrossRefPubMed

12.

Faraone SV, Biederman J (1998) Neurobiology of attention-deficit hyperactivity disorder. Biol Psychiatry 44:951–958CrossRefPubMed

13.

First M, Spitzer R, Gibbon M, Williams J (1997) Structured clinical interview for DSM-IV axis-I disorders (SCID-I). American Psychiatric Press, Washington, DC

14.

Geller B, Zimmerman B, Williams M, Bolhoffer K, Craney JL, et al. (2000) Diagnostic characteristics of 93 cases of a prepubertal and early adolescent bipolar disorder phenotype by gender, puberty and comorbid attention deficit hyperactivity disorder. J Child Adolesc Psychopharmacol 10:157–164CrossRefPubMed

15.

Gillberg C, Gillberg IC, Rasmussen P, Kadesjö B, Söderstöm H, Rastam M (2004) Co-existing disorders in ADHD—implications for diagnosis and intervention. Eur Child Adolesc Psychiatry 13(Suppl. 1):80–92

16.

Horn W (1962) Leistungsprüfsystem. Verlag für Psychologie, Göttingen

17.

Hornig M (1998) Adressing comorbidity in adults with attention-deficit/hyperactivity disorder. J Clin Psychiatry 59(7):69–75PubMed

18.

Kent L, Craddocok N (2003) Is there a relationship between attention deficit hyperactivity disorder and bipolar disorder? J Affect Dis 73:211–221CrossRefPubMed

19.

Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, Demler O, et al. (2006) The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication (NCS-R). Am J Psychiatry 163(4):716–723CrossRefPubMed

20.

Kessler RC, Berglund P, Demler O, Jin R, Walters E (2005) Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62:593–602CrossRefPubMed

21.

Kooij JJS, Burger H, Boonstra AM, Van der Linden PD, Kalma LE, Buitelaar JK (2004) Efficacy and safety of methylphenidate in 45 adults with attention-deficit/hyperactivity disorder. A randomized placebo-controlled trial. Psychol Med 34:973–982CrossRefPubMed

22.

Manuzza S, Klein RG, Bessler A, et al. (1993) Adult outcome of hyperactive boys. Educational achievement, occupational rank, and psychiatric status. Arch Gen Psychiatry 50(7):565–567

23.

McGough JJ, Smalley SL, McCracken JT, Yang M, Del’Homme M, et al. (2005) Psychiatric comorbidity in adult attention deficit hyperactivity disorder: findings from multiplex families. Am J Psychiatry 162(9):1621–1627CrossRefPubMed

24.

Murphy KR, Barkley RA, Bush T (2002) Young adults with attention deficit hyperactivity disorder: subtype differences in comorbidity, educational and clinical history. J Nerv Ment Dis 190(3):147–157CrossRefPubMed

25.

Nierenberg AA, Miyahara S, Spencer T, Wisniewski SR, Otto MW, et al. (2005) Clinical and diagnostic implications of lifetime comorbidity of attention-deficit/hyperactivity disorder in adults with bipolar disorder. Data from the first 1000 STEP-BD participants. Biol Psychiatry 57(11):1467–1473CrossRefPubMed

26.

Perkonigg A, Wittchen HU (1995) Epidemiology of anxiety disorders. In: Kasper S, Möller HJ (eds) Anxiety and panic disorders Fischer, Jena, Stuttgart, pp 137–156

27.

Rasmussen P, Gillberg C (2000) Natural outcome of ADHD with developmental coordination disorder at age 22 years: a controlled, longitudinal, community-based study. J Am Acad Child Adolesc Psychiatry 39(11):1424–1431CrossRefPubMed

28.

Retz-Junginger P., Retz W, Blocher D, Stieglitz R-D, Georg T, Supprian T, Wender PH, Rösler M (2003) Validity and reliability of the German short version of the Wender–Utah rating scale for the retrospective assessment of attention-deficit/hyperactivity disorder. Nervenarzt 74:987–993CrossRefPubMed

29.

Rösler M, Retz W, Retz-Junginger P, Hengesch G, Schneider M, Supprian T, et al. (2004) Prevalence of attention-deficit-/hyperactivity disorder (ADHD) and comorbid disorders in young male prison inmates. Europ Arch Psychiatry Clin Neurosci 254:365–371CrossRef

30.

Satterfield JH, Schell A (1997) A prospective study of hyperactive boys with conduct problems and normal boys: adolescent and adult criminality. J Am Acad Child Adolesc Psychiatry 36(12):1726–1735CrossRefPubMed

31.

Schweickert LA, Strober M, Moslowitz A (1997) Efficacy of methylphenidate in bulimia nervosa with comorbid attention-deficit/hyperactivity disorder. Int J Eat Dis 21:299–301CrossRef

32.

Secnik K, Sneusen A, Lage MJ (2005) Comorbidities and costs of adult patients diagnosed with attention–deficit hyperactivity disorder. Pharmacoeconomics 23(1):93–102CrossRefPubMed

33.

Shekim W, Asarnow RF, Hess E, et al. (1990) A clinical and demographic profile of a sample of adults with attention deficit hyperactivity disorder, residual state. Compr Psychiatry 31:416–425CrossRefPubMed

34.

Spencer T, Biederman J, Wilens T, Doyle R, Surman C, Prince J, et al. (2005) A large double-blind, randomized trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder. Biol Psychiatry 57:456–463CrossRefPubMed

35.

Sullivan MA Rudnik-Levin F (2000) Attention-deficit/hyperactivity disorder and substance abuse: diagnostic and therapeutic considerations. Ann N Y Acad Sci:251–270

36.

Ward KF, Wender PH, Reimherr FW (1993) The Wender Utah rating scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. Am J Psychiatry 150:885–890PubMed

37.

Weiss G, Hechtman L, Milroy T, et al. (1985) Psychiatric status of hyperactives as adults: a controlled prospective 15-year follow-up of 63 hyperactive children. J Am Acad Child Adolesc Psychiatry 24:211–223CrossRef

38.

West S, McElroy, Strakowski S, Keck P, McConville B (1995) Attention-deficit hyperactivity disorder in adolesecent mania. J Affect Disord 51:145–151

Titel: Psychiatric comorbidity and functional impairment in a clinically referred sample of adults with attention-deficit/hyperactivity disorder (ADHD)
verfasst von: Esther Sobanski
Daniel Brüggemann
Barbara Alm
Sebastian Kern
Monika Deschner
Thomas Schubert
Alexandra Philipsen
Marcella Rietschel
Publikationsdatum: 01.10.2007
Verlag: Springer-Verlag
Erschienen in: European Archives of Psychiatry and Clinical Neuroscience / Ausgabe 7/2007
Print ISSN: 0940-1334
Elektronische ISSN: 1433-8491
DOI: https://doi.org/10.1007/s00406-007-0712-8

Neu im Fachgebiet Psychiatrie

17.04.2024 | Delir nicht substanzbedingt | Nachrichten

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Psychiatric comorbidity and functional impairment in a clinically referred sample of adults with attention-deficit/hyperactivity disorder (ADHD)

Abstract

Objective

Method

Results

Conclusion

Neu im Fachgebiet Psychiatrie

Delir kann Demenz begünstigen

Zunahme von Geschlechtsinkongruenz und -dysphorie registriert

Vitiligo: Prävalenz steigt und viele Erkrankte werden spät behandelt

Impostor-Syndrom häufig bei Hyperhidrose zu finden

Update Psychiatrie

Springer Medizin

Abstract

Objective

Method

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2007

Predictive eye and hand movements are differentially affected by schizophrenia

Is depression a risk factor for heart complaints?

Topiramate reduced aggression in female patients with borderline personality disorder

The efficacy of the combination of sertraline with buspirone for smoking cessation

Efficacy of olanzapine versus quetiapine on cognitive dysfunctions in patients with an acute episode of schizophrenia

Season of birth in siblings of patients with seasonal affective disorder

Neu im Fachgebiet Psychiatrie

Delir kann Demenz begünstigen

Zunahme von Geschlechtsinkongruenz und -dysphorie registriert

Vitiligo: Prävalenz steigt und viele Erkrankte werden spät behandelt

Impostor-Syndrom häufig bei Hyperhidrose zu finden

Update Psychiatrie